Welcome to our dedicated page for Confluent SEC filings (Ticker: CFLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Confluent, Inc. (NASDAQ: CFLT) files reports and disclosures with the U.S. Securities and Exchange Commission (SEC) in connection with its listing on the Nasdaq Global Select Market and its status as a public company. These filings provide detailed information on its data streaming business, financial condition, and significant corporate events.
Among the key documents for CFLT are Form 10-K annual reports and Form 10-Q quarterly reports, which describe Confluent’s operations as a data streaming platform provider, outline its revenue from subscriptions and services, and discuss risks and other disclosures. Investors often review these filings to understand how Confluent presents its business model, including offerings such as Confluent Cloud, Confluent Platform, WarpStream, Confluent Private Cloud, Confluent Intelligence, Streaming Agents, Real-Time Context Engine, and Tableflow.
Confluent also uses Form 8-K current reports to disclose material events. For example, a Form 8-K dated December 8, 2025 describes an Agreement and Plan of Merger with International Business Machines Corporation (IBM) and a wholly owned IBM subsidiary. That filing outlines the proposed merger structure, the cash consideration for shares, the treatment of equity awards, closing conditions, termination rights, and potential termination fees. Other 8-K filings referenced in the available data report the release of quarterly financial results.
On this SEC filings page, users can access Confluent’s historical and ongoing disclosures, including 10-K, 10-Q, and 8-K filings, as well as proxy materials related to the IBM transaction once filed. The platform also surfaces Form 4 insider transaction reports and other ownership-related filings when available, allowing investors to monitor changes in holdings by directors and officers.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents, highlight major risk factors, and clarify complex transaction terms. Real-time updates from the SEC’s EDGAR system help ensure that new CFLT filings, including those related to the pending IBM merger, are quickly available with plain-language explanations.
Form 144 notice for Confluent, Inc. (CFLT) reports a proposed sale of 243,200 common shares with an aggregate market value of $4,922,368.00. The sale is to be executed on 09/09/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The securities were acquired and paid for on 09/09/2025 by exercise of stock options from the issuer, with payment in cash. The filing indicates no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Form 144 notice from Confluent, Inc. (CFLT) reports a proposed sale of 1,626,667 common shares through Morgan Stanley Smith Barney LLC on NASDAQ. The filing lists an aggregate market value of $32,923,740.08 and reports total shares outstanding of 291,931,187. The shares were acquired as Founders Shares on July 21, 2020 from the issuer and no securities of the issuer were reported sold by the seller in the past three months. The notice includes the seller's representation that they are not aware of undisclosed material adverse information and indicates the filing is live.
Edward J. Kreps, who is identified as both Chief Executive Officer and a director of Confluent, Inc. (CFLT), reported same-day non-derivative transactions in the issuer's common stock on 09/04/2025. The Form 4 shows 232,500 shares of Class A common stock were acquired (transaction code C) and an equal number, 232,500 shares were sold (transaction code S) at prices reported in a range from $18.35 to $18.955 and an aggregate per-share reference of $18.66 on the form. Following the reported transactions, the filing lists 377,074 shares of Class A common stock beneficially owned directly by the reporting person. The filing also discloses multiple indirect holdings of Class A common stock held in family trusts totaling disclosed blocks of 149,984 and two 1,000,000-share holdings, and a large block of Class A shares shown as underlying Class B conversion.
Confluent, Inc. (CFLT) filed a Form 144 reporting a proposed sale of 5,000 common shares by a person for whose account the securities are to be sold. The shares were granted as restricted stock units acquired on 05/20/2024 and the seller plans to execute the sale approximately on 09/08/2025 through Morgan Stanley Smith Barney LLC. The filing reports an aggregate market value of $96,700 for the 5,000 shares and shows 291,931,187 shares outstanding.
The notice also discloses a prior sale by the same person: 26,097 common shares sold on 08/20/2025 for gross proceeds of $443,909.97. The filer affirms they have no undisclosed material adverse information and cites Rule 144/10b5-1 representations as applicable.
The Vanguard Group reports beneficial ownership of 31,019,643 shares of Confluent Inc common stock, representing 10.62% of the class. Vanguard discloses it holds 28,922,013 shares with sole dispositive power and an additional 2,097,630 shares with shared dispositive power. Voting authority is reported as 0 shares with sole voting power and 1,742,103 shares with shared voting power.
The filing states these holdings are held in the ordinary course of business on behalf of Vanguard clients, who have rights to dividends and sale proceeds, and that the securities were not acquired to change or influence control of the issuer.
Confluent, Inc. (CFLT) Form 144: This notice reports a proposed sale of 465,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $8,941,950 based on the filing. The shares represent a portion of total outstanding common shares of 291,931,187 and are scheduled for sale on 09/04/2025 on NASDAQ. The filing indicates the shares were acquired as Founders Shares on 09/27/2019 and were paid for in cash at acquisition.
The filing also discloses recent 10b5-1 sales by the same person in the past three months: 232,500 shares on 06/05/2025 (gross proceeds $5,695,203.75), 232,500 shares on 08/14/2025 (gross proceeds $3,993,675.75), and 37,707 shares on 08/20/2025 (gross proceeds $642,429.24). The notice includes the standard Rule 144 and 10b5-1 representations but provides no additional operational or financial disclosures about Confluent.
Insider sale under trading plan: Eric Vishria, a director of Confluent, Inc. (CFLT), reported an open-market sale of 30,953 shares of Class A common stock on 08/28/2025 at a reported price of $20 per share executed pursuant to a 10b5-1 trading plan adopted December 13, 2024. After the reported transaction, the filing shows beneficial ownership of 1,123,447 shares held indirectly by entities controlled by the reporting person, and an additional 20,861 shares disposed of on a separate line. The filing is a routine Section 16 Form 4 disclosure documenting the director's change in ownership and confirms the sale was pre-planned under a Rule 10b5-1 arrangement.
Form 144 filing for Confluent, Inc. (CFLT) reports a proposed sale of 953 common shares through Morgan Stanley Smith Barney with an aggregate market value of $17,964.05 and an approximate sale date of 08/28/2025. The filer acquired these shares on 09/26/2014 as an in-kind distribution post-IPO and lists total outstanding shares of 291,931,187.
The filing also discloses recent 10b5-1 sales on 06/05/2025: THE VISHRIA REVOCABLE TRUST sold 15,000 shares for $375,000 and THE KHAKAL TRUST sold 476 shares for $11,900. The signer certifies no undisclosed material adverse information and references reliance on trading-plan provisions where applicable.
Confluent, Inc. (CFLT) Form 144 notice: The filer proposes to sell 30,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $565,500, and an approximate sale date of 08/28/2025 on NASDAQ. The filing reports 291,931,187 shares outstanding. The shares were acquired as an in-kind distribution post IPO on 09/16/2014. The filing also discloses recent 10b5-1 sales in the past three months: 15,000 shares for $375,000 and 476 shares for $11,900 on 06/05/2025. The signer represents no knowledge of undisclosed material adverse information and, if applicable, cites reliance on a Rule 10b5-1 plan.
Confluent, Inc. (CFLT) Form 4: The reporting person, Chief Accounting Officer Phan Kong, sold 2,664 shares of Class A common stock on 08/20/2025 to cover tax obligations from RSU vesting. Sale prices ranged from $17.01 to $17.08, and the reporting person owned 237,078 shares following the transaction. The Form 4 was signed by an attorney-in-fact on 08/22/2025.